在线电生强氧化剂钴(Ⅲ)化学发光法测定地塞米松磷酸钠

本文基于Co3+在硫酸介质中能氧化地塞米松磷酸钠产生化学发光这一特性,建立了一种流动注射化学发光测定地塞米松磷酸钠的新方法。其中不稳定的强氧化剂Co3+是通过在硫酸介质中恒电流电解CoSO4在线产生的,从而消除了由于试剂不稳定性带来的一些不利因素。该方法测定地塞米松磷酸钠的线性范围为1～20 mg/L,检出限为3.2×10－7g/mL(DL=3S/r),相对标准偏差小于5%。该方法已成功地用于地塞米松磷酸钠注射液中地塞米松磷酸钠的测定。     

Spectrophotometric determination of nitrite and nitrate using phosphomolybdenum blue complex

A method for spectrophotometric determination of nitrite and nitrate is described. This method is based on the reduction of phosphomolybdic acid to phosphomolybdenum blue complex by sodium sulfide. The obtained phosphomolybdenum blue complex is oxidized by the addition of nitrite and this causes a reduction in intensity of the blue color. The absolute decrease in the absorbance of the blue color or the rate of its decrease is found to be directly proportional to the amount of nitrite added. The absorbance of the phosphomolybdenum blue complex is monitored spectrophotometrically at 814 nm and related to the concentration of nitrite present. The effect of different factors such as acidity, stability of the complex, time, temperature, phosphate concentration, molybdenum concentration, sodium sulfide concentration and the tolerance amount of other ions have been reported. Maximum absorbance is at 814 nm. The range of linearity using the conventional method is 0.5-2.0 ppm with molar absorptivity of 1.1 x 10(4) l mol(-1) cm(-1). and a relative standard deviation of 2.6% for five measurements. The range of linearity using the reaction rate method is 0.2-3.6 ppm with a relative standard deviation of 2.4% for five measurements. The method is applied for determination of nitrite and nitrate in water, meat products and vegetables.     

Indirect atomic-absorption spectrophotometric determination of phosphorus after flotation as the ion-pair of molybdophosphate with bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolato]cobalt(III)

An atomic-absorption spectrophotometric method has been developed for the indirect determination of phosphorus. The calibration graph is linear over the range 0.025-0.2 mug of phosphorus. The relative standard deviation is 1.3% for 0.2 mug of phosphorus (6 replicates). The method has been applied to the determination of phosphate in natural water samples. The enhancement effect of acetone on the determination is discussed.     

Chemiluminescence flow sensor with immobilized reagent for the determination of pyrogallol based on potassium hexacyanoferrate(III) oxidation

A novel chemiluminescence (CL) flow-through sensor for the determination of pyrogallol has been developed. The method is based on the reaction between pyrogallol and potassium hexacyanoferrate(III) in sodium hydroxide solution. Potassium hexacyanoferrate(III) involved in the CL reaction was electrostatically immobilized on anion-exchange resin packed in a column. Pyrogallol was sensed by the CL reaction between pyrogallol and potassium hexacyanoferrate(III) which was eluted from the ion-exchange column through sodium phosphate injection. The CL emission allows quantitation of pyrogallol concentration in the range 0.01-3.8 microg/mL with a detection limit (3 sigma) of 0.003 microg/mL and a sample throughput of 118 h(-1). The relative standard deviation (n=7) was 2.2% for 0.2 microg/mL of pyrogallol. The influence of foreign compounds was tested.     

Analysis of ethambutol and methoxyphenamine by capillary electrophoresis with electrochemiluminescence detection

A capillary electrophoresis (CE) coupled with electrochemiluminescence (ECL) detection method for the analysis of ethambutol (EB) and methoxyphenamine (MP) has been investigated. Complete separation of EB and MP was achieved in 8 min using a background electrolyte of 20 mM sodium phosphate at pH 10.0 and a separation voltage of 9 kV. ECL detection was performed with an indium/tin oxide (ITO) working electrode biased at 1.4 V (versus a Pt wire reference) in a 200 mM sodium phosphate buffer (pH 8.0) containing 3.5 mM Ru(bpy)3(2+) (where bpy = 2,2'-bipyridyl). Linear correlation (r > or = 0.993) between ECL intensity and drug concentration was obtained in the range 2-50 ng/ml. The limits of detection (LODs) for EB and MP in water were 1.0 and 0.9 ng/ml, respectively. The relative standard deviation values on peak size (10 ng/ml level) and migration time for the two drugs were in the ranges 5-8 and 0.2-0.7% (n = 7), respectively. Applicability of the CE-ECL method to the analysis of human plasma spiked with EB and MP was examined. The LODs for EB and MP in plasma were 0.4 and 0.3 microg/ml, respectively.     

Development and validation of a method for quantitative determination of econazole nitrate in cream formulation by capillary zone electrophoresis

A simple, fast, inexpensive and reliable capillary zone electrophoresis (CZE) method for the determination of econazole nitrate in cream formulations has been developed and validated. Optimum conditions comprised a pH 2.5 phosphate buffer at 20 mmol L(-1) concentration, +30 kV applied voltage in a 31.5 cm x 50 microm I.D. capillary. Direct UV detection at 200 nm led to an adequate sensitivity without interference from sample excipients. A single extraction step of the cream sample in hydrochloric acid was performed prior to injection. Imidazole (100 microg mL(-1)) was used as internal standard. Econazole nitrate migrates in approximately 1.2 min. The analytical curve presented a coefficient of correlation of 0.9995. Detection and quantitation limits were 1.85 and 5.62 microg mL(-1), respectively. Excellent accuracy and precision were obtained. Recoveries varied from 98.1 to 102.5% and intra- and inter-day precisions, calculated as relative standard deviation (RSD), were better than 2.0%. The proposed CZE method presented advantageous performance characteristics and it can be considered suitable for the quality control of econazole nitrate cream formulations.     

Flow analysis-spectrophotometric determination of L-Dopa in pharmaceutical formulations by reaction with p-aminophenol

A new method has been developed for the spectrophotometric determination of L-Dopa in pharmaceutical formulations. The method is based on the reaction between the open-chain quinone of L-Dopa, obtained in NaOH, and the benzoquinoneimine form of p-aminophenol, in the presence of KIO(4). The reaction product is determined at 574 nm by using both alternately procedures, one based on the stopped-flow and another on a flow injection approach. Under the best experimental conditions L-Dopa can be determined with a limit of detection of 52 ng/ml and a relative standard deviation of 0.2% for three replicate measurements of a solution containing 4 microg/ml.     

Determination of folic acid in tablets by microemulsion electrokinetic chromatography

A microemulsion electrokinetic chromatography (MEEKC) method has been developed and validated for the determination of folic acid, a water-soluble vitamin, in a commercial tablet formulation. The analysis was performed using a microemulsion containing 0.5% (w/w) ethyl acetate, 1.2% (w/w) butan-1-ol, 0.6% (w/w) sodium dodecyl sulfate, 15% (v/v) 2-propanol and 82.7% (w/w) 10 mmol L(-1) sodium tetraborate aqueous buffer at pH 9.2. Direct UV detection at 214nm led to an adequate sensitivity without interference from sample excipients. For quantitative purposes, niacin was used as internal standard. Acceptable precision (<1.2% relative standard deviation (R.S.D.)), linearity (r = 0.9992; range from 160.0 to 240.0 microg/mL), sensitivity (limit of detection (LOD) = 2.98 microg/mL; limit of quantification (LOQ) = 9.05 microg/mL) and recovery (99.8 +/- 1.8% at three concentration levels) were obtained. Based on the performance characteristics, the proposed methodology was found suitable for the determination of folic acid in tablet formulations.     

The High-Performance Thin-Layer Chromatographic Determination of Dexamethasone and Xylometazoline in Nasal Drops Containing Different Preservatives

JPC – Journal of Planar Chromatography – Modern TLC - A simple and reliable HPTLC method has been developed and validated for the determination of dexamethasone (as the sodium phosphate...     

Determination of coenzyme Q by non-aqueous reversed- phase liquid chromatography.

A non-aqueous reversed-phase liquid chromatographic method for determination of coenzyme Q10 in pharmaceutical formulations has been developed. The reversed-phase system provides better reproducibility and better selectivity for the separation of coenzyme Q10 analogues and degradation products than studied normal-phase systems. Furthermore, the non-aqueous mobile phase showed a very good solubility and provides a greater variety of work-up solvents for the lipophilic formulations than aqueous mobile phases. Validation studies showed detector response linearity over a concentration range of 0.2-100 micrograms/ml. The lower limit of detection was 2 ng on-column. The intra-assay precision (relative standard deviation) for a soybean oil formulation was 2.0% (n = 11).     

Determination of ceftriaxone sodium in pharmaceutical formulations by flow injection analysis with acid potassium permanganate chemiluminescence detection.

Based on the chemiluminescence (CL) emission generated from the oxidation of ceftriaxone sodium alkali hydrolysate by potassium permanganate in polyphosphoric acid (PPA), a novel determination method for ceftriaxone sodium was developed by using a flow-injection technique. The calibration curve appears to be linear in the range between 0.05 and 100 microg mL(-1) with a detection limit (3sigma) of 25 ng mL(-1), and a relative standard deviation (RSD) of 0.6% for eleven replicate determinations of 5.0 microg mL(-1) ceftriaxone sodium. The proposed method has been successfully utilized for the determination of ceftriaxone sodium in pharmaceutical formulations, while the chemiluminescence reaction mechanisms were investigated.     

Simultaneous determination of N-butylscopolamine and oxazepam in pharmaceutical formulations by first-order digital derivative spectrophotometry

A simple method has been developed for the simultaneous determination of N-butylscopolamine bromide and oxazepam in pharmaceutical formulations using first-order digital derivative spectrophotometry. Acetonitrile was selected as the solvent in which both compounds showed well-defined bands. Both analytes showed good stability in this solvent when solutions of the analytes were exposed to light and temperatures between 20 degrees and 80 degrees C. The simultaneous determination of both drugs was performed by the zero-crossing method at 226.0 and 257.0 nm for N-butylscopolamine and oxazepam, respectively. The linear range of determination was found to be 2.5 x 10(-7) to 8.0 x 10(-5) mol/L for N-butylscopolamine and 7.1 x 10(-8) to 8.0 x 10(-5) mol/L for oxazepam. A very good level of repeatability (relative standard deviation) of 0.2% was observed for N-butylscopolamine and oxazepam. The ingredients commonly found in pharmaceutical formulations do not interfere. The proposed method was applied to the determination of these drugs in pharmaceutical formulations (capsules).     

HPLC determination and pharmacokinetics of chlorogenic acid in rabbit plasma after an oral dose of Flos Lonicerae extract

A simple and sensitive high-performance liquid chromatography (HPLC) method has been developed for the determination of chlorogenic acid (3-O-caffeoyl-D-quinic acid) in plasma and applied to its pharmacokinetic study in rabbits after administration of Flos Lonicerae extract. Plasma samples are extracted with methanol. HPLC analysis of the extracts is performed on a C(18) reversed-phase column using acetonitrile-0.2% phosphate buffer (11:89, v/v) as the mobile phase. The UV detector is set at 327 nm. The standard curves are linear in the range 0.0500-1.00 microg/mL (r = 0.9987). The mean extraction recovery of 85.1% is obtained for chlorogenic acid. The interday precision (relative standard deviation) ranges from 5.0% to 7.5%, and the intraday precision is better than 9.0%. The limit of quantitation is 0.0500 microg/mL. The plasma concentration of chlorogenic acid shows a C(max) of 0.839 +/- 0.35 microg/mL at 34.7 +/- 1.1 min and a second one of 0.367 +/- 0.16 microg/mL at 273.4 +/- 39.6 min.     

Ion-chromatographic determination of chromium (VI)

Summary A simple ion-chromatographic method has been developed for the selective determination of chromium (VI) using UV-photometric detection. The anion exchanger was based on a matrix of a 2-hydroxyethyl-methacrylate copolymer; the mobile phase consisted of phosphate buffer and sodium perchlorate. The relative standard deviation was 2.26%. Application was made to waste waters of the metallurgical industry.     

Determination of Dexamethasone in Cosmetics by MEKC

A rapid and reliable method based on micellar electrokinetic capillary chromatography has been developed for the determination of dexamethasone in cosmetics. Effects of buffer composition, concentration and pH, the detection wavelength, separation voltage, and injection time were systematically investigated. The optimum conditions were: 30 mM borax buffer containing 20 mM sodium dodecyl sulfate at pH 9.0, detection at 254 nm, injection time 10 s at a height of 10 cm, and a separation voltage of 15 kV. Under these conditions, the analysis of dexamethasone in cosmetics was carried out within 6 min. The method was validated for stability, precision, linearity and accuracy. Excellent linearity was obtained in the range of 50–1,000 μg mL⁻¹, and acceptable precision, in intra-day and inter-day analysis, was also obtained with relative standard deviation in the range of 0.19–0.86 and 2.50–4.90% for migration time and peak area ratio, respectively. The method was used to analyse eight cosmetic samples purchased locally.     

Determination of trazodone in urine and pharmaceuticals using micellar liquid chromatography with fluorescence detection

A simple and reliable liquid chromatographic procedure is described for the determination of trazodone in pharmaceutical formulations and urine samples. The optimized procedure uses fluorimetric detection, a C18 column and a micellar mobile phase of sodium dodecyl sulfate (SDS) and 1-butanol. The mobile phase selected for use was 0.2M SDS and 8% 1-butanol fixed at pH 3 with phosphate buffer. The total analysis time was 10 min. For the analysis of urine samples, one great advantage of the method is that no extraction step is required. The quantification limit was 9.5 ng mL(-1), ensuring the analysis of the drug in biological fluids. The procedure shows good accuracy, repeatability and selectivity. Repeatability and intermediate precision were tested for several concentrations of the drug. Good claim percentages were obtained in the analysis of pharmaceutical formulations. Calibration repeatability in urine matrix was also studied in the 0.06-22.4 microg mL(-1) range. Good recoveries were obtained from spiked urine samples. No interferences from common additives frequently administered with trazodone or from endogenous compounds in urine samples were found. The results show that the procedure is suitable for routine analysis of the drug.     

Simultaneous determination of chlorpheniramine maleate and dexamethasone in a tablet dosage form by liquid chromatography

An accurate, simple, reproducible, and sensible liquid chromatographic method was developed and validated for the determination of chlorpheniramine maleate and dexamethasone in a tablet formulation. The analysis was performed at room temperature on a reversed-phase C18 column with UV detection at 254 nm. The mobile phase consisted of 7.5 mM monobasic potassium phosphate in methanol-water (62.5 + 37.5) at a constant flow rate of 1 mL/min. The method was validated in terms of linearity, precision, accuracy, and specificity by forced decomposition of chlorpheniramine maleate and dexamethasone initiated by using acid, base, water, hydrogen peroxide, heat, and light. The response was linear in the ranges of 0.04-0.12 and 0.006-0.016 mg/mL for chlorpheniramine maleate (r2 = 0.9999) and dexamethasone (r2 = 0.9994), respectively. The relative standard deviation values for intra- and interday precision studies were 2.39 and 2.02, respectively, for chlorpheniramine maleate and 2.39 and 1.25, respectively, for dexamethasone. Recoveries ranged from 95.07 to 101.95% for chlorpheniramine maleate and from 97.75 to 102.10% for dexamethasone.     

Towards minimization of chlorinated solvents consume in Fourier transform infrared spectroscopy determination of Propamocarb in pesticide formulations

A method has been developed for Fourier transform infrared (FTIR) spectroscopy determination of Propamocarb in emulsifiable pesticide concentrate formulations. Five microliter sample was directly injected without any pretreatment in a CHCl3 stream at 2 mL min(-1) into a closed system and the FTIR spectra of sample and standard solutions were obtained using a nominal resolution of 4 cm(-1) from 4000 to 900 cm(-1) spectral region and accumulating 2 scans per spectrum. Propamocarb determination was based on the measurement of flow injection analysis (FIA) recording height established from FTIR peak area measurements from 1713 to 1703 cm(-1) corrected using a baseline defined at 2000 cm(-1). The concentration of Propamocarb in samples was calculated by interpolation in an external calibration line obtained from several injections of 2 microL of a 47% (w/v) standard solution into the CHCl3 closed system. This procedure provided a limit of detection of 0.8% (w/v) in the original sample, a sensitivity of 0.3190 absorbance units mL mg(-1) for a path length of 0.11 mm and a relative standard deviation of 0.2% for five independent measurements at 0.74 mg mL(-1) concentration level. The maximum sampling frequency of the whole procedure was 34 h(-1) and the waste generation was reduced to only 2 mL of CHCl3 solution per sample and additional 2 mL for the whole calibration line.     

Capillary electrophoresis and circular dichroism study of trichosanthin and its mutants

A new chromogenic reagent, 2-(2-quinolylazo)-5-diethylaminoaniline (QADEAA) was synthesized. A highly sensitive, selective and rapid method for the determination of silver based on the rapid reaction of silver (I) with QADEAA has been developed. In the presence of sodium citrate-sodium hydroxide buffer solution (pH 6.5) and sodium dodecyl sulfonate (SDS) medium, QADEAA reacts with silver to form a violet complex of molar ratio 1:2 (silver to QADEAA). The molar absorptivity of the complex is 1.39x10(5) l mol(-1) cm(-1) at 580 nm. Beer's law is obeyed in the range of 0.01-0.6 mug ml(-1). The relative standard deviation for 11 replicate samples of 0.2 mug ml(-1) is 1.67%. This method can be applied to the determination of silver in water with satisfactory results.     

Fluorometric determination of 3,4-dihydroyphenylalaine in pharmaceutical formulation by reaction with paracetamol

A new method has been developed for the fluorometric determination of 3,4-dihydroxyphenylalaine (l-dopa) in pharmaceutical formulations. The reaction product, belonging to fluorescent species, has the excitation and emission maxima at 410 and 510 nm, respectively. Under the optimum conditions, responses were linear between 0.06-4.0 and 4.0-12.0 mug ml(-1). The detection limit, corresponding to a signal-to-noise ratio of 3, was 1 ng ml(-1). The relative standard deviation (n=10) was 0.6%. The proposed method was applied to determination of l-dopa in pharmaceutical formulations.